HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma α-Glutathione S-Transferase in Patients with Chronic Mesenteric Ischemia and Median Arcuate Ligament Syndrome.

AbstractBackground:
Chronic mesenteric ischemia (CMI) due to either atherosclerosis of the mesenteric arteries or median arcuate ligament syndrome (MALS) is an underdiagnosed entity. The etiology of MALS and its existence have been debated and questioned. We aimed to identify plasma biomarkers indicating mesenteric ischemia in patients with CMI and MALS.
Methods:
Plasma α-glutathione S-transferase (α-GST), intestinal fatty acid-binding protein (I-FABP), citrulline, and ischemia modified albumin (IMA) were analyzed in fifty-eight patients with CMI (Group A, n=44) and MALS (Group B, n=14) before and after revascularization. The plasma levels of these potential biomarkers were compared with those of healthy individuals (Group C, n=16). Group comparison was performed with the Mann-Whitney U-test. Cross-tabulation and its derivatives were obtained. Receiver operating characteristic (ROC) curves and area under the curve (AUC) were calculated.
Results:
Plasma levels of α-GST were significantly raised in the patients with CMI (7.8 ng/mL, p<0.001) and MALS (8.4 ng/mL, p<0.001), as compared with the control Group C (3.3 ng/mL). The threshold for normal median plasma α-GST levels of 4 ng/mL yielded a sensitivity of 93% and 86%, specificity of 86% and 88%, respectively, for the diagnosis of CMI due to atherosclerosis and MALS. AUC of ROC curves was 0.96 (p<0.0001) for CMI and 0.85 (p<0.002) for MALS. The patient groups did not differ from the healthy controls in any other biomarkers.
Conclusion:
Plasma α-GST levels are elevated in CMI and MALS patients. Elevated plasma levels of α-GST suggest ischemia as the etiology of MALS.
AuthorsSyed Sajid Hussain Kazmi, Nathkai Safi, Simen Tveten Berge, Marryam Kazmi, Jon Otto Sundhagen, Kari Julien, Per Medbøe Thorsby, Kim Vidar Ånonsen, Asle Wilhelm Medhus, Jonny Hisdal
JournalVascular health and risk management (Vasc Health Risk Manag) Vol. 18 Pg. 567-574 ( 2022) ISSN: 1178-2048 [Electronic] New Zealand
PMID35903288 (Publication Type: Journal Article)
Copyright© 2022 Kazmi et al.
Chemical References
  • Biomarkers
  • Serum Albumin
  • Glutathione Transferase
Topics
  • Atherosclerosis
  • Biomarkers
  • Celiac Artery
  • Chronic Disease
  • Glutathione Transferase
  • Humans
  • Ischemia
  • Median Arcuate Ligament Syndrome (diagnosis)
  • Mesenteric Ischemia (diagnostic imaging)
  • Serum Albumin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: